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The aim of the present study was to review published surveys on allelic frequencies S and Z in Spanish populations
to evaluate the validity of the reported data.
Thirty-four studies published since 1965 were retrieved by MEDLINE, Index Medicus and consultations with
experts. The criteria for studies selection were (i) sample size 250 individuals; (ii) alpha-1-antitrypsin phenotyping
determination performed by means of crossed antigen–antibody electrophoresis or isoelectrofocusing; (iii) S and Z
reported outcomes with an upper 95% CI smaller than mean +2 SD, a lower 95% CI smaller than mean72 SD, and
the following ratio: 1006 (95%CI upper limit — 95%CI lower limit)/allelic frequency, for both S and Z, included
in the mean +2 SD interval.
Thirteen out of 34 surveys retrieved complied with the proposed criteria for S gene frequency analysis and 11
fulfilled the criteria for Z. The greatest frequency for S type is in the north-west of the country (149 alleles per 1000
in Galicians natives), while frequencies in the rest of the country are approximately 100 alleles per 1000. The
greatest frequency for Z type has been reported in newborn infants from Valladolid (20?8) and in a randomly
selected general population of Asturias (19?7). In the rest of Spain, Z frequencies range from 1?5 to 15 alleles per
1000 genes.
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Alpha-1-antitrypsin (AAT) deficiency is a relatively
common inherited condition in Caucasians of Northern
European heritage (1). It occurs as a result of the
inheritance of two deficient alleles from the AAT-gene
locus on chromosomal segment 14q32.1. Alpha-1-antitryp-
sin exists in more than 90 different genetically determined
variants known as the protease inhibitor (Pi) system. The
majority of these variants have no clinical significance.
Each variant is labelled according to its mobility in an acid-
starch-gel as follows: Z, very slow; S, slow; M, medium; and
F, fast. They are inherited as autosomal-codominant alleles,
and Pi phenotypes are determined by the independent
expression of two parental alleles (2). Alpha-1-antitrypsin
deficiency is associated with an increased risk of developing
pulmonary emphysema in adult life and liver disease in
children and adults (2,3).
Epidemiologically, the most important variants are Pi
types M (which occurs in 90% of white, normal individualsReceived 9 May 2000 and accepted in revised form 4 September
2000.
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In clinical practice, 95% of the individuals with severe AAT
deficiency are the Pi ZZ type (1,3). Heterozygotes of Pi SZ
type have approximately one-third of the normal AAT
serum concentration, but the association of this phenotype
with clinical diseases is less clear (4). No excessive risk
appears to be attached to phenotypes SS, MZ and MS
(2–4).
Although the estimated frequency of AAT deficiency in
Europe and North America is between 1 in 2000 and 1 in
7000, this disorder appears to be widely underdiagnosed
(1). Calculations based on reported gene frequencies
suggest that only a small proportion (10%) of patients
predicted to have severe AAT deficiency have been
diagnosed. Since human AAT is available for replacement
therapy (5), knowledge of AAT-deficiency prevalence in a
specific community is very important for developing
strategies for enhancing awareness of it among healthcare
givers and the general public, and for exploring disease
prevention and therapeutic strategies (1).
Although it is thought that severe AAT deficiency,
phenotype Pi ZZ, is a rare condition in Spain (6) prevalence
of severe AAT deficiency in this country has not been
clearly reported. A recent published survey has shown that
there is a high Pi Z allele frequency and a very high Pi SZ
prevalence among a randomly selected general population# 2001 HARCOURT PUBLISHERS LTD
110 I. BLANCO AND E. FERNA´NDEZfrom the north of Spain (7). Since most Spanish studies on
this topic are written in Spanish, they are not commonly
known outside Spanish-speaking countries, but it is
recognized that there is a very high frequency of allele S
in the Iberian Peninsula (8). This review is an assessment of
the published surveys on Pi Z and S gene frequencies in the
Spanish population, with the aim of establishing the true
prevalence of AAT deficiency in Spain.
Methods
DATA SOURCES
The literature review began with a computerized
MEDLINE search using the terms ‘alpha-1-antrypsin Pi
types’, ‘population studies’ and ‘Spain’. The search
included articles published between 1965 and 2000. Index
Medicus was used to locate articles not included in the
MEDLINE search. References in these studies were also
checked for usable surveys. Experts of the Spanish Registry
of patients with severe AAT deficiency were contacted to
obtain surveys not included in MEDLINE or Index
Medicus.
Descriptive and outcome data from every retrieved
survey were independently abstracted by the authors.
Discussion and consensus were used to resolve discrepan-
cies in the abstracted data.
DETAILS OF STUDIES
Methodological characteristics and outcomes of 34 surveys
reviewed by the authors (7–29) are shown in Table 1. Gene
frequencies have been expressed as the total number of S
and Z, whether in homozygotes or heterozygotes per 1000
genes of all Pi types. If gene frequencies or 95% confidence
intervals (95% CI) were not given by the authors, they have
been calculated from the quoted phenotype frequencies.
The gene frequency has been obtained by adding the total
number of alleles S or Z, and expressing this number as a
fraction of the total number of Pi alleles in the population;
the total number of alleles is twice the number of the
subjects.
The first survey on Pi phenotypes of the Spanish
population was carried out in 1968 in Oslo, Norway, by
Fagerhol and Tenfjord (8). These investigators studied 378
Spanish seamen (the majority of them Galatians) hired in
Norwegian ports, as part of a routine health control for
syphilis antibody screening. The following study (9) was
performed by Goedde et al. in 1973 on four Spanish
populations: Basques, Galatians, Andalucians and a sample
of people from the Meseta Central population. Since 1980,
29 other studies on several communities have been reported
by Spanish investigators. These studies have been per-
formed in: Madrid, Barcelona, Galicia, Valladolid, Min-
orca, Majorca, Basque Country, Andalusia, Pyrenees,
Gerona, Santander, Tenerife and Asturias.
The sample size in the series ranges from 50 to 1116
subjects. A wide range of subjects have been chosen for
study in various surveys, including: seamen, blood donors,children with coeliac disease, patients with chronic
obstructive pulmonary disease (COPD), hospital staff,
students, newborn infants, natives from small isolated
communities, healthy controls, work-based employees and
general population not selected at random. Only a survey
carried out in Asturias (7) has been performed on a general
population selected at random. In some studies, the subjects
recruited are imprecisely described as ‘randomly selected’ or
‘unrelated persons’, although selection procedures are often
not given in detail. Initial studies (8,9) have been performed
by means of crossed antigen–antibody electrophoresis
(XAA), a laborious technique which usually gives
results in agreement with modern and reliable methods.
Twenty-five other studies have been carried out by the
trustworthy method of isoelectric focusing in polyacrila-
mide gels (IEF). A Spanish study (14) was performed
using the less reliable technique of starch-gel electro-
phoresis (SG).
SELECTION OF STUDIES
A survey (not quoted in Table 1) in which phenotypes were
identified after an initial screening procedure for selecting
sera with an ATT-serum level below the normal value (30)
has been omitted from analysis, because this could give an
excessive number of deficient alleles.
A study in which phenotypes were characterized by
means of the SG method (14) has been omitted, because
gene frequency Z may be significantly underestimated by
this method.
Due to the fact that 95% CI for a given population size at
a determinate gene frequency is wide, especially when gene
frequency is low, it has been suggested that the number of
subjects for a study on this topic should be at least 250 (or
500 alleles) (31). Surveys with a sample size lower than 250
subjects have been rejected, because this fact could increase
the possibility of an erroneous estimation of true gene
frequencies.
On the basis of the above expounded criteria, 13 studies
were selected (7,8,11–13,15,17,18,20–22,25,28). The next
step was to calculate the arithmetic mean (X) and standard
deviation (SD) of the upper and lower values of the reported
95% CI for S and Z outcomes. The obtained values were:
184 for the upper limit of S (X+2 SD); 38 for the lower limit
of S (X72 SD); 48?5 for the upper limit of Z (X+2 SD); and
a negative value for the lower limit of Z (X72 SD). All of
the 13 selected surveys comply with criteria for S; but one
survey did not comply for Z (15), and was consequently
refused. The following ratio was calculated for both S
and Z: 1006 (95%CI upper limit 795%CI lower limit)/
allelic frequency. A calculated ratio value included in
the X+2SD interval was accepted as valid. This calculated
ratio ranged from 19 to 59% for S, and from 36 to 704%
for Z. The reported data for Z-gene frequencies did not
have a normal distribution, so a logarithmic transformation
was done to calculate the lower and upper values of the Z
ratio. Based on these criteria, one study (11) was rejected
because its Z-calculated ratio exceeded the established
limits.
TABLE 1. Details and allelic frequencies of S and Z Pi types (expressed in absolute number of alleles per 1000) in 34 Hispanic
populations
Place Subjects
(no.)
Subject
source
S-gene frequency
(95% CI)
Z-gene frequency
(95% CI)
Method Author
(reference)
Norway 378 Seamen* 112 (91–138) 11?9 (5?8–23?3) XAA Fagerhol (8)
Madrid 170 NRS 97 (69–135) 0 (0–2?1) XAA Goedde (9)
Seville 131 NRS 99 (67–144) 11?4 (3–36) XAA Goedde (9)
Lugo 129 NRS 147 (108–198) 3?9 (0.2–24?8) XAA Goedde (9)
Pamplona 146 NRS 116 (83–160) 6?9 (1?2–27?2) XAA Goedde (9)
Madrid 93 Patients 91 (56–145) 5?4 (0?3–34?2) IEF Klasen (10)
Madrid 103 Children 83 (50–151) 0 (0–3?6) IEF Klasen (10)
Barcelona 398 NRS 64 (49–84) 1 (0?4–2?0) IEF Moral (11)
Compostela 496 Natives BD 139 (119–163) 8 (3?8–16?5) IEF Caeiro (12)
Galicia 480 Natives BD 149 (127–173) 9 (4?6–18?4) IEF Carracedo (13)
Valladolid 50 NRS 0 (0–0?71) 0 (0–7?1) SG Gonza´lez (14)
Madrid 553 BD 75 (61–93) 48 (36?4–62?7) IEF Suerio (15)
Madrid 244 H.staff 49 (32–73) 84 (62–113) IEF Suerio (15)
Madrid 68 COPD 105 (60–170) 80?9 (43?1–143?5) IEF Suerio (15)
Pyrinees 170 Natives 141 (107–184) 0 (0–3?5) IEF Moral (16)
Minorca 445 Natives 83 (66–104) 9 (4?2–18?4) IEF Moral (17)
Vitoria 99 BD 131 (89–188) 5 (0?3–32?1) IEF Estefanı´a (18)
Vizcaya 56 Natives BD 107 (59–183) 0 (0–6?4) IEF Estefanı´a (18)
Vizcaya 166 Natives BD 118 (86–158) 15 (5?6–36?8) IEF Estefanı´a (18)
Bilbao 390 BD 108 (87–132) 6 (2?4–15?8) IEF Estefanı´a (18)
S Sebastia´n 155 BD 126 (92–169) 0 (0–2?4) IEF Estefanı´a (18)
Andalusia 200 BD 90 (65–124) 0 (0–1?8) IEF Prados (19)
Gerona 291 Natives 74 (55–99) 5 (1?3–16?3) IEF Moreno (20)
Valladolid 457 Newborn 135 (114–159) 20?8 (12?9–32?9) IEF Andre´s (21)
Basque country 706 NRS 99 (84–116) 8 (4?1–14?3) IEF Garcı´a-Orad (22)
Pyrinees 146 Natives 147 (110–194) 0 (0–2?4) IEF Moreno (23)
Majorca 137 Majorcan Jews 51 (29–86) 4 (0?2–23?4) IEF Picornell (24)
Alava 323 Natives 101 (79–127) 1?5 (0?1–10) IEF Manzano (25)
Gredos 106 Natives 109 (72–160) 0 (0–3?4) IEF Moral (26)
Gredos 97 Natives 88 (53–139) 5 (0?3–32?8) IEF Moral (26)
Santander 100 Natives 145 (101–203) 15 (3?9–46?8) IEF De Grado (27)
Barcelona 440 NRS 105 (86–127) 15 (8?2–25?8) IEF Vidal (28)
Tenerife 108 Natives 144 (101–199) 9 (1?6–36?6) IEF Moral (29)
Asturias 1116 GP 100 (88–113) 19?7 (14?5–26?6) IEF Blanco (7)
*Spanish seamen hired on Norwegian ships (most of them Galicians); NRS: non-randomly selected sample; BD: blood
donors; H: hospital; COPD: patients with chronic obstructive pulmonary disease; GP: randomly selected general population;
CI: confidence interval; XAA: crossed antigen-antibody electrophoresis; IEF: isoelectric focusing; SG: starch-gel
electrophoresis.
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According to the criteria explained above, only studies with
a sample size 250 individuals (or 500 alleles), an ATT-
phenotyping determination performed by means of XAA or
IEE, an upper 95% CI smaller than X+2SD, a lower 95%
CI smaller than X72SD, and a calculated ratio value for S
and Z reported outcomes included in the X+2SD interval,
were included for analysis. Applying these criteria, 13 out
of 34 surveys have been validated for a Pi S frequency
analysis, and 11 of these 13 fulfil the established criteria for
a Pi Z evaluation.Details and outcomes of selected surveys are shown in
Table 2. Geographical distribution of Pi S and Pi Z
frequencies are shown in Figs 1 and 2. Gene frequencies
have been expressed as the total number of S and Z,
whether in homozygotes or heterozygotes, per 1000 genes
of all Pi types. Prevalence of the SZ phenotype has
been calculated by applying the Hardy-Weinberg
principle, as twice the product of the respective gene
frequencies for S and Z types. Prevalence of homozygote
Z has been also calculated by means of the Hardy-
Weinberg principle, as the square of the frequencies for
allele Z.
TABLE 2. Gene frequencies S and ZZ (expressed as the total number of S and Z genes per 1000 genes of all types) and
prevalence of SZ and ZZ (calculated using the Hardy-Weinberg principle) in selected Spanish surveys
Author
(Reference)
Source
and place of the subjects
S-gene frequency
(95% CI)
Z-gene frequency
(95% CI)
SZ prevalence ZZ prevalence
Fagerhol (8) NRS (Norway) 112 (91–138) 11?9 (5?8–23?3) 1/374 1/7056
Moral (11) NCS (Barcelona) 64 (49–84) — — —
Caeiro (12) Natives BD (Galicia) 139 (119–163) 8 (3?8–16?5) 1/446 1/15376
Carracedo (13) Natives (Galicia) 149 (127–173) 9 (4?6–18?4) 1/358 1/11378
Suerio (15) BD (Madrid) 75 (61–93) — — —
Moral (17) Natives (Minorca) 83 (66–104) 9 (4?2–18?4) 1/669 1/12377
Estefanı´a (18) BD (Bilbao) 108 (87–132) 6 (2?4–15?8) 1/724 1/24336
Andre´s (21) NB (Valladolid) 135 (114–159) 20.8 (12?9–32?9) 1/179 1/2314
Moreno (20) Natives (Gerona) 74 (55–99) 5 (1?3–16?3) 1/1313 1/37636
Garcı´a-Orad (22) NCS (Bilbao) 99 (94–116) 8 (4?1–14?3) 1/647 1/16447
Manzano (25) Natives (Alava) 101 (79–127) 1?5 (0?1–10) 1/3210 1/417316
Vidal (28) NRS (Barcelona) 105 (86–127) 15 (8?2–25?8) 1/324 1/4582
Blanco (7) GP (Asturias) 100 (88–113) 19?7 (14?5–26?6) 1/254 1/2577
NRS: non-randomly selected sample; NCS: not clearly specified subjects; BD: blood donors; NB: newborn; GP: randomly
selected general population; CI: confidence interval.
FIG. 1. Distribution of Pi S type in 13 selected Spanish
populations. The greatest frequency is on the north-
western coast of the country (Galicia). The value declines
gradually from west to east of Spain. Gene frequency per
1000.
FIG. 2. Distribution of Pi type Z in 11 selected Spanish
surveys. The highest figures have been obtained in
newborn infants from Valladolid and in general
population selected at random from Asturias.
Discrepancies in Pi Z gene prevalence in the remaining
provinces could be explained because of the different
sources of the subjects studied. Gene frequency per 1000.
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The greatest frequency for S type in Spain (Fig. 1) is on the
north-west coast of the country, with values ranging from
112 in Galician seamen (8) to 149 per 1000 in Galician
blood donors (13). A very high S frequency (135 per 1000)
has also been reported in newborn infants from Valladolid,
Meseta Septentrional (21). The frequency of S type
gradually decreases from west to east all over Spain. In
Asturias, a contiguous province to Galicia located on the
Cantabrian coast, an allelic frequency for S of 100 has been
reported in a general population selected at random (7).
Similar figures have been noted in the Basque Country(18,22,25), with values ranging from 99 in natives to 108 in
blood donors. In Catalonia, Pi S-type reported frequencies
are: 64 and 105 in non-randomly selected subjects from
Barcelona (11,28), and 74 in natives from Gerona (20). In
natives of Minorca island (17), a value of 83 has been
reported. Finally, a value of 75 has been reported in blood
donors of Madrid (15).
The greatest frequency of S type in Europe has been
obtained in the Iberian Peninsula, particularly in Galicia
and Portugal (31). The high gene frequency in these regions
suggests that the S mutation may have arisen in the north of
the Iberian Peninsula. The value gradually declines all over
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east, ranging from 4100 in the south-west to 520 in the
east (31).
Geographical distribution of Pi Z type in Spain is shown
in Fig. 2. Reported frequencies for Z type range from 8 to
11?9 in Galicia (8,12,13); 19?7 in Asturias (7); 1?5 to 8 in
Basque Country (25,18,22); 20?8 in Valladolid (21); 5 to 15
in Catalonia (20,28); and 9 in Minorca (17). Differences in
the reported Pi Z gene frequencies could be explained by
the different sources of the subjects studied. Ten out of the
11 Spanish studies mentioned above have been carried out
using sera of non-randomly selected healthy subjects.
Moreover, some surveys performed in natives from isolated
communities, which are potentially of great ethnographic
interest, could yield different gene frequencies in respect to
the general population. As in clinical practice, 95% of the
individuals with severe AAT deficiency are Pi ZZ type.
These circumstances could exclude Z phenotypes associated
with pathology, and studies on hospital-based populations
or similar should be considered with caution for an
accurate interpretation of their results.
The distribution of gene frequency for type Z in Europe
differs markedly from type S. It is accepted that frequencies
of type Z in most European countries are less than for the
S type. Although the data is rather less firm, nowadays
there is no doubt that the greatest gene frequency for Z type
is on the north-western coast of the continent (31). As with
the S type, the gene frequency for Z type in higher in the
western regions of the continent. Both types are very rare
outside of the European stock. One of the most common
genetic disorders in Caucasians is Z type AAT deficiency,
but it is extremely rare in non-Caucasians (32). According
to Byth et al. (33), the Z allele probably has a relatively
recent origin (about 2000 years ago or 66 generations; each
generation ¼ 30 years). The most likely site of origin seems
to have been southern Scandinavia, due to the high gene
frequency in that area. The highest frequencies of Pi Z type
in Europe have been reported in natives of the Baltic Sea
regions (34): 47 per 1000 in western Latvia; 35 per 1000 in
eastern Latvia; 32 per 1000 in southern and central Sweden;
and 30 per 1000 on the Swedish island of Gotland. The
value gradually declines from west to east and from north
to south all over the continent, ranging from 420 in the
west to 55 in the east.
Phenotype Pi SZ individuals are borderline subjects at
risk for the development of pulmonary emphysema. More-
over, some investigators have reported isolated cases of
liver disease associated with this heterozygous Pi phenotype
(2–4). The geographical distribution of the deficient
heterozygous SZ phenotype is influenced by the high gene
frequency for S type. It shows a similar decrease from west
to east all over the European continent. The highest
calculated figure has been obtained in Asturias (1 in 254)
falling to about 1 in 5000 in eastern Europe. The most
reliable calculation of Pi SZ phenotype prevalence in a
region of Spain has been 1 in 254 in Asturias (7). Figures in
Galicia are slightly lower than in Asturias (1 in 358 to 1 in
450). Reported SZ prevalence in Basque country and
Catalonia are very erratic. A possible explanation for these
divergences could be that as the SZ prevalence is calculatedby means of the Hardy-Weinberg principle (twice the
product of the respective gene frequencies for S and Z
types), an incorrect estimation of allelic frequencies S and Z
(related to an inappropriate selection of the samples) could
miscalculate the true SZ prevalence.
Calculated prevalence of Pi ZZ phenotype in a general
population of Asturias selected at random is 1 in 2577.
Calculated Pi ZZ prevalences in the remaining Spanish
population are very variable. Comparing data of Pi ZZ
prevalence in Asturias with those reported in a recently
published review (31), it seems that this north-Spanish
region has a Pi Z gene frequency similar to several
European populations with a high Pi Z gene frequency,
including: Norway, Sweden, Denmark, Nothern Ireland,
South-West England, London, Normandy, Brittany,
Bordeaux, Lisbon, Germany and Tyrol.
In conclusion, according to the results of the present
study, AAT SZ and ZZ deficiency is not a rare disease in
Spain. Pi S gene frequency is higher than most frequencies
reported in the rest of Europe. Heterozygous Pi SZ
prevalence in the north of Spain is the highest reported in
the world. Finally, in some northern Spanish regions, Pi Z
type frequency and calculated Pi ZZ prevalence are similar
to those reported in other European countries with a high
Pi Z frequency and Pi ZZ prevalence.
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